USPTO serial 87150877
Reviewed by CopyMark Law Group
Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use. Continue use in commerce and plan for the 10-year Section 8 and 9 renewal.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Karen Kreider Gaunt
Karen Kreider Gaunt Dinsmore & Shohl LLP255 EAST FIFTH STREET, SUITE 1900CINCINNATI, OH 45202United States| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Injectable bone substitute material consisting of natural materials; injectable bone material consisting of natural materials for treatment of osteoporotic fractures; injectable bone filler consisting of natural materials for tissue generation; living tissue, cells and/or molecules produced in vitro for replacement and/or support of the function of missing or injured body parts; bone void fillers consisting of natural materials; [ bone fillers consisting of living materials; ] bone void fillers consisting of natural materials; [ bone growth media consisting of biological materials for medical purposes; pharmaceutical products and preparations for the treatment of bone diseases; ] pharmaceutical products and preparations for the treatment of bone fractures; injectable osteoconductive materials consisting of natural materials; injectable radiopaque bone substitute consisting of natural materials; natural bioceramic bone substitutes; bone remodelling materials consisting of natural materials; pharmaceutical preparations for use within [ general surgery, urology, odontology, ] orthopedic surgery *;* [ and cosmetic surgery; ] biological preparations for treatment of fractures, osteoporotic fractures, and bone voids caused by trauma, infection, disease or associated surgery; natural biomaterial for augmentation of bone and tissue for medical purposes; ceramics for medical purposes, namely ceramics for use within general surgery, urology, odontology, orthopedic surgery and cosmetic surgery; biological bone implant material | ACTIVE | — |
| 010 | [ Hypodermic injectors; medication injectors; ] injection syringes; [ needles for syringes; ] injection device for pharmaceuticals; injectors for medical purposes; apparatus, instruments and equipment for preparing of injectable bone substitute material; apparatus, instruments and equipment for injecting injectable bone substitute material; bone substitutes for surgical use; substitutes for bones; non-biological bone implant material; artificial bone materials; artificial bone materials of ceramics; artificial bone parts to be implanted in natural bones; apparatus, instruments and equipment for preparing and application of pharmaceutical preparations for medical purposes; containers for bone substitutes; mixing instruments for medical purposes; injection instruments as well as instruments for preparing and making the injection easier; instruments and equipment for preparing and application of biological preparations for medical purposes; apparatus, instruments and equipment for preparing and application of biomaterials for medical purposes; apparatus, instruments and equipment for preparing and application of ceramic material for medical purposes; apparatus, instruments and equipment instruments for preparing and application of bone substitute material for medical purposes; apparatus, instruments and equipment instruments for preparing and application of preparations used in surgery, [ urology, odontology, ] orthopaedic [ , and cosmetic ] operations; artificial bone substitutes and bone expanders for odontological, [ cosmetically and ] operative procedures; parts and fittings for the aforementioned goods; biphasic injectable ceramic bone substitute | ACTIVE | — |
| 041 | Education, namely, provision of teaching and training in the field of the development and commercialization of injectable bio-ceramic composites for patients suffering from bone disorders; provision of teaching and training in relation to apparatus, instruments and equipment in connection with injectable bone substitute material; provision of teaching and training in relation to injectable bone substitute material; provision of teaching and training in relation to bone disease and the impact upon bones of various cancers; provision of teaching and training in relation to [ medicine, ] medical techniques, medical technical products and medical services; provision of teaching and training for medical and healthcare professionals in the field of the development and commercialization of injectable bio-ceramic composites for patients suffering from bone disorders; [ provision of teaching and training in relation to osteopathy; ] provision of teaching and training in relation to bone filling and implant services; advisory and consultancy services relating to the aforementioned | ACTIVE | — |
| 042 | Scientific and technological services namely, scientific research, analysis, and testing, in the field of the development and commercialization of injectable bio-ceramic composites for patients suffering from bone disorders and research and design relating thereto; [ medical and pharmacological research and development services; ] analysis of medical and technical research and development; industrial analysis and research services in the field of the development and commercialization of injectable bio-ceramic composites for patients suffering from bone disorders; clinical research in the field of the development and commercialization of injectable bio-ceramic composites for patients suffering from bone disorders; clinical trials [ for others ] relating to the development and commercialization of injectable bio-ceramic composites for patients suffering from bone disorders; conducting clinical trials and research in the field of bone disease; conducting clinical trials and research in the field of for injectable bone substitutes, materials and fillers; design and development of computer software in connection with injectable bone substitute material, injecting bone substitute material, preparing bone substitute material and equipment therefor; information, advisory and consultancy services relating to the aforementioned; development and commercialization of injectable bio-ceramic composites for patients suffering from bone disorders | ACTIVE | — |
| 044 | [ Medical imaging services; medical testing for diagnostic or treatment purposes; ] medical information; [ rental of medical equipment; leasing of medical equipment; medical screening; medical counselling; ] medical consultation; [ charitable services, namely, providing medical services; medical services for the treatment of bone cancer and tumours; medical services for the treatment of bone disease; medical services in connection with injectable bone substitute material; medical services in connection with injecting bone substitute material; diagnostic, medical and treatment services in connection with preparing bone substitute material and equipment therefor; ] advisory and consultancy services relating to the aforementioned | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Feb 19, 2025 | NA85 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | — |
| Feb 19, 2025 | C15A | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | — |
| Feb 19, 2025 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Oct 11, 2024 | E815 | TEAS SECTION 8 & 15 RECEIVED | — |
| Oct 30, 2023 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Oct 30, 2018 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Sep 24, 2018 | DP1B | 1(B) BASIS DELETED; PROCEED TO REGISTRATION | — |
| Sep 24, 2018 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Sep 4, 2018 | IUCN | NOTICE OF ALLOWANCE CANCELLED | — |
| Sep 4, 2018 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Sep 4, 2018 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Sep 4, 2018 | D1BR | TEAS DELETE 1(B) BASIS RECEIVED | — |
| Jul 3, 2018 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| May 8, 2018 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| May 8, 2018 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 18, 2018 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Apr 2, 2018 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 22, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 22, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 22, 2018 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 9, 2018 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 9, 2018 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 9, 2018 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 8, 2018 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Feb 6, 2018 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Jan 22, 2018 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 18, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 17, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 17, 2018 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 18, 2017 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 18, 2017 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 18, 2017 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 14, 2017 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 14, 2017 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 7, 2017 | ALIE | ASSIGNED TO LIE | — |
| Jun 4, 2017 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 6, 2016 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 6, 2016 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 6, 2016 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 6, 2016 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 1, 2016 | MDSM | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Aug 31, 2016 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 29, 2016 | NWAP | NEW APPLICATION ENTERED | — |